Premium
Metformin does not improve survival of cholangiocarcinoma patients with diabetes
Author(s) -
Yang Zhen,
Zhang Xiaodan,
Roberts Rosebud O.,
Roberts Lewis R.,
Chaiteerakij Roongruedee
Publication year - 2016
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27821
Subject(s) - metformin , medicine , hazard ratio , odds ratio , intrahepatic cholangiocarcinoma , confidence interval , proportional hazards model , cancer , hepatology , diabetes mellitus , oncology , endocrinology , insulin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom